ARPA-H launches $63M effort to build FDA-authorized AI agents for heart failure care

A major government investment aims to develop regulated clinical AI agents, advancing medical AI capability under FDA oversight.

Auto-scored: Substantive government-funded effort to create FDA-authorized clinical AI agents, with minor risk from capability advancement. · Review in the editor.